Buy One Get One free -Llimited Time Offer X
Oxra 10 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes Type 2.
Medical history of the patient along with age and gender determines the dosage of Oxra 10 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Oxra 10 Tablet as well, which are listed below. Normally, these side effects of Oxra 10 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Oxra 10 Tablet's effect during pregnancy is Severe and Unknown while nursing. In addition, Oxra 10 Tablet's effects on the liver, heart and kidney are discussed below in the Oxra 10 Tablet related warnings section.
Oxra 10 Tablet is contraindicated in people with pre-existing medical conditions like Bladder Cancer, Kidney Disease as it can result in adverse effects. Other contraindications of Oxra 10 Tablet have been discussed in the sections ahead.
Drug reaction of Oxra 10 Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Oxra 10 Tablet is safe while driving, and is is addictive in nature.
Oxra 10 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Oxra 10 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Oxra. If you are pregnant, do not take Oxra without a doctor's advice.
Is the use of Oxra 10 Tablet safe during breastfeeding?
There is no research available on the side effects of Oxra in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Oxra 10 Tablet on the Kidneys?
Kidney can be affected by Oxra. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Oxra 10 Tablet on the Liver?
You may experience side effects on your liver after taking Oxra. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Oxra 10 Tablet on the Heart?
In the absence of any scientific study on the side effects of Oxra on the heart, information on safety of Oxra for the heart is unavailable.
If you are suffering from any of the following diseases, you should not take Oxra 10 Tablet unless your doctor advises you to do so -
Is this Oxra 10 Tablet habit forming or addictive?
No, you will not get addicted to Oxra 10 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Oxra 10 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Oxra 10 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Oxra 10 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Oxra 10 Tablet
There is no information on the effects of taking Oxra 10 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Oxra 10 Tablet
Consult your doctor before consuming alcohol while taking Oxra 10 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278